Kevin Moran
Chief Financial Officer
Replay available
Vanda Pharmaceuticals Inc. (VNDA) Q2 2025 Earnings Call
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Q2 2025 earnings conference call, held 2025-07-31. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Mahalis Polymeropoulos
President, Chief Executive Officer, and Chairman of the Board
Ram Selvaraju
Analyst, HC Wainwright
Olivia Breyer
Analyst, Cantor Fitzgerald
Andrew Chai
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vanda Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.942 -- 00:00:03.524 Good day everyone and thank you for standing by. 00:00:03.524 -- 00:00:07.468 My name is RG and I will be your conference operator today. 00:00:07.468 -- 00:00:13.073 At this time, I would like to welcome everyone to the Q2 2025 00:00:13.073 -- 00:00:16.997 Vanda Pharmaceuticals, Inc. Earnings Conference Call. 00:00:16.997 -- 00:00:21.381 All lines have been placed on mute to prevent any background noise. 00:00:21.381 -- 00:00:25.745 After the speaker's remarks, there will be a question and answer session. 00:00:25.745 -- 00:00:30.483 If you would like to ask a question during this time, simply press star followed by the 00:00:30.483 -- 00:00:35.430 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:35.430 -- 00:00:40.598 star one again. Thank you. I would now like to turn the call over to Vanda's 00:00:40.598 -- 00:00:45.325 Chief Financial Officer, Kevin Moran. Please go ahead. 00:00:45.325 -- 00:00:50.392 Great. Thank you, R.G. Good morning, and thank you for joining us to discuss Vanda Pharmaceutical's 00:00:50.392 -- 00:00:55.419 second quarter 2025 performance. Our second quarter 2025 results 00:00:55.419 -- 00:01:00.532 were released this morning and are available on the SEC's EDGAR system and on our website, 00:01:00.532 -- 00:01:02.532 www.vandafarma.com. 00:01:03.454 -- 00:01:07.218 In addition, we are providing live and archived versions of this conference call on our 00:01:07.218 -- 00:01:09.740 website. Joining me on today's call is Dr. 00:01:09.740 -- 00:01:14.425 Mahalis Polymeropoulos, our President, Chief Executive Officer, and Chairman of the Board, 00:01:14.425 -- 00:01:18.869 and Tim Williams, our General Counsel. Following my introductory remarks, Mahalis will 00:01:18...